🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
CONTESSA 2 is a multinational, multicenter, Phase 2 study of tesetaxel in p...
Status
Terminated
Location
Innovative Clinical Research Institute
Start Date
2019-02-05
Trial ID
NCT03858972
Treatments Being Tested
The intravenously administered taxane, paclitaxel, is one of the most commo...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2010-11
Trial ID
NCT01221870
Treatments Being Tested
This study is being conducted to compare the efficacy and safety of tesetax...
Status
Unknown
Location
The West Clinic
Start Date
2012-05
Trial ID
NCT01609127
Treatments Being Tested
CONTESSA TRIO is a multi-cohort, multicenter, Phase 2 study of tesetaxel, a...
Status
Terminated
Location
Sarah Cannon Research Institute - Florida Cancer Specialists
Start Date
2019-07-09
Trial ID
NCT03952325
Treatments Being Tested
Given the activity of docetaxel in patients with progressive, metastatic ca...
Status
Unknown
Location
University of Michigan Health System
Start Date
2011-02
Trial ID
NCT01296243
Treatments Being Tested
This study is being performed to evaluate the efficacy and safety of capeci...
Status
Unknown
Location
The University of Texas MD Anderson Cancer Center
Start Date
2012-04
Trial ID
NCT01573468
Treatments Being Tested
The goal of this clinical research study is to learn if tesetaxel can help ...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2010-02
Trial ID
NCT01064713
Treatments Being Tested
The intravenously administered taxanes, docetaxel and paclitaxel, alone and...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2010-09
Trial ID
NCT01215877
Treatments Being Tested
Tesetaxel is an orally administered chemotherapy agent of the taxane class....
Status
Unknown
Location
The University of Texas MD Anderson Cancer Center
Start Date
2010-02
Trial ID
NCT01092585
Treatments Being Tested
Tesetaxel is an orally administered chemotherapy agent of the taxane class....
Status
Unknown
Location
Northwestern Medical Faculty Foundation
Start Date
2010-03
Trial ID
NCT01095120
Treatments Being Tested